На главную
Результаты поиска “Ucla urology prostate cancer latest treatments”
Focal therapy – prostate cancer treatment that doesn’t involve erectile dysfunction or incontinence
UCLA urologist Leonard S. Marks, MD, is pursuing a new frontier in prostate cancer treatment — focal therapy, which uses various approaches to target cancer, resulting in fewer side effects. Meet the physician and his patients who traveled to UCLA as far as Florida for this effective therapy. The treatment is not for everybody, but for a large segment of the prostate-cancer population, UCLA offers something that has never been available before. Video for Vital Signs, a UCLA Health publication providing consumers with health news they can use. Learn more at https://www.uclahealth.org/vitalsigns/focal-therapy-offers-advanced-treatment-options-for-prostate-cancer
Просмотров: 6266 UCLA Health
Active Surveillance for Prostate Cancer | Dr. Christopher Saigal - UCLA Urology
Learn more about the latest treatment for prostate cancer at http://urology.ucla.edu
Просмотров: 13067 UCLA Health
Curing prostate cancer with ultrasound: HIFU arrives at UCLA | #UCLAMDCHAT Webinars
UCLA urologist Leonard Marks, MD, as he discusses HIFU (high intensity focused ultrasound), an FDA-approved method for treating prostate cancer. Dr. Marks will address the advantages of HIFU over traditional treatments and its implementation at UCLA. Browse more webinars at www.uclahealth.org/uclamdchat
Просмотров: 11801 UCLA Health
Making Decisions After Being Diagnosed with Early Stage Prostate Cancer | UCLAMDCHAT Webinar
Making treatment decisions after being diagnosed with early stage prostate cancer can be difficult for some men, with many options and risks to consider. Join UCLA urologist Christopher Saigal, MD who talks about an organized process called “shared decision making” that can help a man choose the right treatment for him. Learn more: http://urology.ucla.edu/
Просмотров: 4140 UCLA Health
Prostate Cancer - Now What? - Stuart Holden, MD | #UCLAMDChat Webinars
UCLA Urologist, Stuart Holden, MD, discusses prostate cancer and the latest treatment options. Learn more about UCLA Urology at http://urology.ucla.edu
Просмотров: 1105 UCLA Health
Active Surveillance - Watchful Waiting for Prostate Cancer | UCLA Urology - Dr. Leonard Marks
Channel 11 Highlights UCLA Active Surveillance Program Dr. Leonard Marks, a clinical professor of urology, was featured Sept. 2 in a Fox 11 News story on UCLA's active surveillance program that forgoes surgical treatment for prostate cancer patients in favor of close monitoring and periodic biopsies. Learn more about Active Surveillance & Watchful Waiting: http://urology.ucla.edu/body.cfm?id=246 Video courtesy FOX News
Просмотров: 6418 UCLA Health
Emerging Therapies for Upper Tract Urothelial Carcinoma | UCLA Urology
Join UCLA urologist Nicholas Donin, MD, for a discussion about a new treatment for upper tract urothelial carcinoma involving a unique thermosensitive polymer that allows sustained delivery of chemotherapy directly to the site of tumors in the upper urinary tract. Dr. Donin will address data from a new randomized clinical trial.
Просмотров: 397 UCLA Health
Localized Prostate Cancer: Progress Toward Personalized Care
(Visit: http://www.uctv.tv/) There were 233,000 new cases of prostate cancer in the US last year. The good news is that there has been 40% drop in age-adjusted prostate cancer mortality since early 1990s. Dr. Matthew Cooperberg, Associate Professor of Urology at UCSF, talks about screening, treatment and risk assessment. He also explains the concept of active surveillance. Recorded on 07/22/2014. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2014] [Health and Medicine] [Show ID: 28503]
Просмотров: 6789 University of California Television (UCTV)
Testicular Cancer: Latest Treatments | Dr. Mark S. Litwin - UCLA Urology
Learn more about the latest treatments for testicular cancer at http://urology.ucla.edu/.
Просмотров: 18276 UCLA Health
Rob Reiter, MD - UCLA Prostate Cancer Program | UCLA Urology
Dr. Reiter is the Bing Professor of Urologic Oncology and Director of UCLA's prostate cancer program. He is Principal Investigator on UCLA's Prostate Cancer SPORE, a 12 million dollar federal grant that is focused on translational research in prostate cancer. Learn more about his work at https://www.uclahealth.org/robert-reiter
Просмотров: 1682 UCLA Health
Focal Therapy For Prostate Cancer Gives Patient Full Recovery, Fewer Side Effects
Ron received a cancer diagnosis the day before his 58th birthday. It all started with a prostate-specific antigen (PSA) test, a common blood test given to men to identify issues with their prostate. “It wasn’t super high, but it was high enough that a biopsy was recommended,” said Ron, a commercial real estate business owner in Lodi. Everything progressed pretty quickly after I got my results. Within a month or two, I had to start making some choices and the options weren’t really appealing.” Discover more patient stories at http://stanfordhealthnow.org
Просмотров: 1663 Stanford Health Care
(2) AUA 2017 Best Video: From Targeted Biopsy To Focal Therapy of Prostate Cancer
At the American Urology Association annual meeting, Dr. Leonard Marks and his team from UCLA presented their work on treating prostate cancer in the urology clinic via focal laser ablation (FLA). It was awarded "best video" of the 2017 conference.
Просмотров: 64675 Targeted Prostate Biopsy
Signs and Symptoms of Prostate Cancer - A Physician's and Patient's Perspective | Dr. Mark Litwin
UCLA urologist Mark S. Litwin, MD, MPH, and his patient, former Major League Baseball player Steve Garvey, discuss prostate cancer. Learn about the tests, treatments and latest advancements in prostate cancer care from Dr. Litwin and hear a patient's perspective. Learn more at http://urology.ucla.edu
Просмотров: 178641 UCLA Health
Urology Centers of Alabama offers a new treatment for Prostate Cancer.
Dr. Andrew Strang, of Urology Centers of Alabama, discusses HIFU, the latest treatment for prostate cancer. This newly FDA approved treatment allows men to receive the benefit of treatment, with a lower risk of common side effects.
Просмотров: 345 UrologyCenterAL
New prostate cancer treatment- Natural Prostate  Treatment - Natural - Effective- no side effect
For prostate cancer, our treatment consists of several steps. First, we determine the location and size of the prostate cancer lesions by Digital Rectal Examination (DRE), Trans Rectal UltraSound (TRUS), and pelvic Nuclear Magnetic Resonance Imaging (MRI) examination. And then we targeted inject a set of anti-cancer herbal extracts without any side effects into the prostate cancer lesion area in high concentrations by using 3D targeted injection technology, thus directly inhibiting and killing cancer cells, making the prostate cancerous tissue atrophy and necrotize. At the same time, we targeted inject unblocking herbal extracts without any side effects to resolve the pathogenic tissue and prostatic endotoxin, and discharge toxic substances. In addition, we use some other herbal extracts without any side effects to improve and restore prostate immunity and the blood circulation to prevent the recurrence of prostate cancer. Through 3D Prostate Targeted Treatment, the volume of the prostate cancer lesions will shrink or disappear, and the patient’s symptoms should be improved or disappear. At the first and second clinical stages (I-II stages), prostate cancer lesion is only confined to the prostate capsule. At this time, we inject a set of anti-cancer herbal extracts and unblocking herbal extracts within the prostate cancer lesion for treatment. At the third clinical stage (III stage), prostate cancer lesion goes beyond the prostate capsule and invades neighboring tissues and organs like seminal vesicle, bladder neck etc. We targeted inject treatment medicines within the prostate capsule to treat the primary lesion, and we also apply 3D targeted injection technology to put a set of anti-cancer treatment medications into adjacent seminal vesicle, the bladder neck and other neighboring tissues and organs for treatment. At the fourth clinical stage (IV stage), prostate cancer lesion spreads beyond the prostate by transferring lesions to distant bones, or even lungs, liver and adrenal gland. We targeted inject treatment medicines within the prostate capsule to treat the primary lesion; at the same time, we couple with systemic treatment and local targeted injection treatment of distant metastasis lesions. The treatment medications include anti-cancer herbal extracts, unblocking herbal extracts, and improving immunity herbal extracts. Our clinical use of medicines have no side effects. Because prostate cancer normally happens in older people, the cancer nodules will press on the prostate tubes, ejaculatory ducts and posterior urethra, prostate cancer patients usually may also have prostatitis and genitourinary tract infection, 3D Prostate Targeted Treatment can treat these diseases at the same time. 3D Prostate Targeted Treatment is very suitable for prostate cancer patients who also have prostatitis and benign prostatic hyperplasia. 3D Prostate Targeted Treatment is an non-surgical method that causes no harm, no side-effects with no ongoing consequences of the original disease, to completely treat prostate cancer. 3D Prostate Targeted Treatment is not a long-term medicinal treatment and so it is the best treatment for prostate cancer as it causes no side-effects. At present, 3D Prostate Targeted Treatment is not suitable for distant metastases of prostate cancer, including bone metastases, lung metastases, liver metastases and adrenal glands metastases. Mr. John Kennedy Medical report link: https://www.prostatecancer.vip/cancer.html Mr. Barry Saunders Medical report link: https://www.prostatecancer.vip/cancer.html 3D prostatitis and Prostate Clinic Miss Alisa Wang English Assistant to Dr. Song Tel:86-186-7321-6429 WhatsApp:+ 86 -186-73216429 Email: prostatecure3d@gmail.com Website: https://www.prostatecancer.vip/cancer.html The Xiangtan 3D Urology and Prostate Clinics Address - Jin Xiangtan Square Office Building, Suite 801, Shao Shan Middle Rd., Xiangtan, Hunan, China.
Просмотров: 346269 Alisa Wang
Provenge Immunotherapy for Prostate Cancer - Allan J. Pantuck, MD | #UCLAMDChat Webinars
Allan J. Pantuck, MD, MS, FACS, professor in the UCLA Department of Urology discusses the use of Provenge in the treatment of prostate cancer. Dr. Pantuck also discusses the background and rationale for the use of immune-based therapies in the treatment of cancer and the indications, benefits and side effects of Provenge, an FDA-approved treatment for advanced prostate cancer that utilizes the patient’s genetically engineered immune cells. Learn more at http://urology.ucla.edu Learn more about Dr. Allan J. Pantuck at https://uclahealth.org/AllanPantuck
Просмотров: 3619 UCLA Health
Vitamin D and Prostate Cancer
Dr. Thomas E. Keane presented “Vitamin D and Prostate Cancer” at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between October 14th and 16th 2016. STOP-6 was accredited for CME by the European Accreditation Council for CME (UEMS-EACCME). The meeting was organized by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal. Funding to support this educational activity was provided by FERRING Pharmaceuticals. FERRING did not influence meeting content and the views expressed during the meeting represent only those of the faculty.
Просмотров: 2943 Grand Rounds in Urology
UCLA Offers HIFU Treatment for Recurrent Prostate Cancer
UCLA Clinical Trial Offers Additional Option for Patients with Recurrent Prostate Cancer Dwight Baird's prostate cancer had returned after he initially received external beam radiation treatment 22 years ago. He wasn't a candidate for further radiation or surgery to remove the prostate so his options were limited. Dwight chose a new non-invasive treatment currently only being offered through clinical trials at academic sites in the United States - UCLA is the only site on the West Coast. Called HIFU (High Intensity Focused Ultrasound), the technique delivers sound waves aimed at the prostate tissue, which rapidly increases tissue temperature, destroying the cancerous lesions. Three months after Dwight had the HIFU outpatient procedure at UCLA his PSA levels were undetectable. His UCLA urologists, Dr. Leonard Marks and Dr. Allan Pantuck, are pleased with these early results. Although his doctors note that Dwight's experience may not be typical and side effects may vary amongst patients. To qualify for the clinical trial, participants must have recurrent prostate cancer after treatment with external beam radiation therapy. Initial screening visits will involve physical exams, blood tests and an ultrasound of the prostate. Qualifying participants will receive the outpatient HIFU procedure under anesthesia and follow-up for a year after treatment. All study-related costs, including the HIFU treatment, will be covered by the research study. The study is sponsored by Focus Surgery, Inc., manufacturer of the The Sonablate® 500 system, which is the HIFU technology used in the study. Several thousand HIFU procedures have been performed in other countries, but the treatment is currently considered investigational in the United States. The UCLA study is part of an FDA-approved clinical trial. For more information about the study, please call Malu Macairan, research coordinator, at 310-794-3566. Or visit us at www.urology.ucla.edu
Просмотров: 11711 UCLA Health
Medical Management of Benign Prostatic Hyperplasia (BPH) | UCLA Urology
Benign prostatic hyperplasia (BPH) is a non-cancerous condition that affects a substantial number of men as they age, in which the enlarged prostate squeezes or partially blocks the surrounding urethra – the tube that carries the urine from the bladder out of the body. This can lead to bothersome urinary symptoms that may include a weak stream, trouble starting and stopping, the frequent feeling of needing to urinate, greater urgency when the feeling hits, leaking or dribbling, and the sense that the bladder isn’t empty after urination. These symptoms should not be ignored, particularly since there are many good treatment options. Learn more at http://urology.ucla.edu
Просмотров: 10550 UCLA Health
A new approach to prostate cancer treatment?
A clinical trial is testing whether targeting treatments to a genetic anomaly can lead to more targeted treatment for prostate cancer. Learn more about this phase 2 trial for men with castration-resistant metastatic prostate cancer.
Просмотров: 5041 Michigan Medicine
Dwight's Story Update: Prostate Cancer Treatment
Dwight is healthy and cancer-free five years after receiving High Intensity Focused Ultrasound (HIFU). Learn more about HIFU and treatment options for prostate cancer at https://urology.ucla.edu.
Просмотров: 1583 UCLA Health
(3) 3 Men, 3 Different Kinds of Focal Treatment at UCLA
Overview of 3 focal and minimally invasive treatment options for prostate cancer at UCLA: • Cryotherapy • HIFU (high intensity focus ultrasound) • Focal laser ablation All 3 can focally target prostate tumors in an outpatient procedure with minimal side effects.
Просмотров: 82 Targeted Prostate Biopsy
New Method for Detecting and Managing Prostate Cancer | UCLAMDCHAT Webinars
UCLA urologist Robert Reiter, MD, discusses Ga-PSMA PET CT, a new method for detection and visualization of metastatic prostate cancer not previously visible with conventional and molecular imaging techniques. *Ga-PSMA PET CT is now offered at UCLA and aims to improve management of recurrent and high-risk cancers. Watch more webinars at https://www.uclahealth.org/uclamdchat. *Investigational agent. Currently not approved by FDA for imaging prostate cancer.
Просмотров: 16649 UCLA Health
Innovations in Treating Bladder and Kidney Cancer #UCLAMDChat - Karim Chamie, MD
UCLA urologist, Karim Chamie, MD, MSHS, discusses new cancer treatments that do not require the unnecessary removal of the kidney or bladder. Learn more at http://urology.ucla.edu Learn more about our #UCLAMDChats at http://uclahealth.org/uclamdchat
Просмотров: 5174 UCLA Health
(7) Path Towards Focal Therapy of Prostate Cancer at UCLA
Development of the targeting and fusion technology to enable focal laser therapy of prostate cancer. Read here for more information about: (1) Men whose cancer went undetected by conventional biopsy but was picked up by targeted prostate biopsy: http://www.ncbi.nlm.nih.gov/pubmed/23523537 (2) Why we use targeted biopsy to select men for active surveillance: http://ncbi.nlm.nih.gov/pubmed/24512956 (3) How we use patient-specific 3D printing to improve targeting: http://ncbi.nlm.nih.gov/pubmed/25374914 Using the same MR-US fusion technology to perform targeted biopsies, UCLA Urology is in a collaboration with Biomedical Engineering, Radiology, and Pathology to perform focal therapy of the prostate. In this video, the team, lead by Dr. Marks, describes the development of the targeting and fusion technology to allow laser therapy to deliver a minimally invasive treatment, eliminating the side effects of radical surgery.
Просмотров: 2024 Targeted Prostate Biopsy
Radiation Therapy Side Effects for Prostate Cancer Patients
Michael Steinberg, M.D. - UCLA educates patients on the side effects of radiation therapy.
Просмотров: 80877 Prostate Cancer Research Institute
The Latest on Prostate Cancer and Bone Health Webinar
In this program, Benjamin Lowentritt, M.D., F.A.C.S., Medical Director of the Prostate Cancer Care Program at Chesapeake Urology Associates, will address how prostate cancer can affect bone health and what treatments are available both to treat bone metastases and address bone loss as a side effect of prostate cancer treatment. He will also discuss how to stay informed and involved in your treatment and what questions to ask your doctor. Sponsored by Amgen
Просмотров: 156 ZERO - The End of Prostate Cancer
Surveillance Rather than Surgery for Many Patients with Prostate Cancer | UCLA Vital Signs
While PSA testing to screen for prostate cancer has led to more detection, the concept of “active surveillance” is gaining traction as a means to reduce overtreatment of the disease.
Просмотров: 826 UCLA Health
Erectile Dysfunction 101 | #UCLAMDChat Webinars
Join UCLA urologist Caroline Wallner, MD, as she discusses erectile dysfunction, including risk factors to develop the condition, as well as targeted therapies and surgical treatments. Learn more at http://urology.ucla.edu
Просмотров: 266140 UCLA Health
Treatment for prostate cancer
The prostate cancer ( PSA ) is one of the worst deseas or medical condition . The patient has to go to UCLA Urology and do prostatectomy prostate radiation hormonal therapy Brachytherapy Also , are natural prostate treatment , prostate cancer cure , prostate cancer surgery , prostate cancer incontinence. The prostate cancer can make the man impotence.
Просмотров: 28 NoDiseases
Prostate Cancer Breakthrough | UCLA Health
Video courtesy of NBC Learn more at http://urology.ucla.edu
Просмотров: 3099 UCLA Health
Real Questions | Prostate Cancer | UCLA Urology
I would like to know more about the use of seed implant for prostate cancer? Learn more at http://urology.ucla.edu
Просмотров: 124 UCLA Health
Testicular Cancer: What You Really Need to Know | UCLAMDCHAT Webinars
UCLA urologist Mark Litwin Mark Litwin, MD, MPH, chair of the UCLA Department of Urology, and a testicular cancer survivor, as he describes the basics of testicular cancer diagnosis and treatment and the latest in clinical management.
Просмотров: 63551 UCLA Health
Prostate Cancer 101 | #UCLAMDChat Chat
UCLA urologist Christopher Saigal, MD, introduces viewers to the basics of prostate cancer, including anatomy, risk factors and common misconceptions. Learn more about Dr. Christopher Saigal at http://uclahealth.org/ChristopherSaigal Learn more about UCLA Urology at http://urology.ucla.edu
Просмотров: 2746 UCLA Health
Robotic Surgery to remove Prostate Cancer
Barry Broughton is a successful marketing executive who has traveled the world and faced a lifetime of challenges. But few challenges would be as difficult as the diagnosis he received last year of prostate cancer. Barrys cancer was diagnosed following a test called a PSA, or prostate-specific antigen test, which measures a protein produced by the prostate that is elevated in most men with prostate cancer. A rising PSA indicates the likelihood of a growing cancer, and the faster it rises, the more aggressive the cancer is likely to be. He was horrified when he heard the news. Both of my parents died of cancer, and my sister has had her breasts removed so cancer is prevalent in my family, and it was a very traumatic thing to be told, he recalls. Prostate cancer is one of the most-common cancers affecting men. Each year, 220,000 new cases are diagnosed and 29,000 men die from the disease. But that number is down from 40,000 deaths 10 years ago, potentially because of the kind of screening that Barry received. Barry and his physician, UCLA urologist Dr. Robert Reiter, who is the director of the Prostate Cancer Treatment Program at UCLA, talked about his options for treatment, including radiation and different types of surgery. After much discussion, both Barry and Dr. Reiter felt that surgery, using the latest in robotic technology, to remove his cancerous prostate would be Barrys best choice. The technique is minimally invasive, meaning it is performed through small holes in the abdomen through which a camera and instruments are inserted. The instruments have wrist-like joints and can move in all directions, giving the surgeon maximum flexibility and accuracy of movement. In addition, the camera provides three-dimensional images, offering the surgeon an improved visual field as he works the instruments. And because a long incision is not necessary, there is much less blood loss and patients generally experience less pain and faster recovery, often returning home the next day and back to most activities within a few weeks. The efficacy of the surgery is further enhanced at UCLA by the integration of magnetic resonance imaging, which reduces the risks of leaving cancer behind and improves the chances of sexual recovery. After his surgery, Barry was up and walking the next day. He quickly regained urinary and sexual function, and, most important to him and his family, Barry is now cancer free. Theyve got the old guy still around for a while, and were looking for grandchildren one of these days, so we want to be around to be able to enjoy them, Barry says. Thats the deal. Visit www.urology.ucla.edu for more.
Просмотров: 15632 UCLA Health
Treating Prostate Cancer with Radioactive Seed Implants
Dr. Geo Espinosa, ND, LAc, IFMCP, CNS, clinical assistant professor of integrative and functional urology at New York University and author of Thrive—Don’t Survive: Dr. Geo’s Guide to Living Your Best Life Before & After Prostate Cancer, discusses radioactive seed implants as a treatment for prostate cancer. Radioactive seed implants (also known as Brachytherapy or internal radiation therapy) are tiny pellets of radioactive material that are placed around the prostate to kill cancer cells. This treatment method has fallen out of favor, and fewer physicians are being trained in its administration. Why? Because while these seeds may effectively kill cancer cells, they also can cause urinary difficulties, such as urinary frequency and urgency, and infertility, reduced semen production and erectile dysfunction.
Просмотров: 332 Bottom Line Inc
Technologies to Treat Benign Prostatic Hyperplasia | #UCLAMDChat Webinar
UCLA urologist Christopher Saigal, MD, discusses the latest minimally invasive technologies to treat benign prostatic hyperplasia (enlarged prostate gland), which causes significant lifestyle and health problems for some men. Dr. Saigal also discusses medical and dietary changes that help reduce the impact of this condition. Learn more at http://urology.ucla.edu
Просмотров: 3995 UCLA Health
Stanford Experts Offer Latest Prostate Cancer Information
As part of prostate cancer awareness month, a panel of Stanford Hospital & Clinics experts share the latest screening and treatment information about the disease, the second leading cause of death among American men. Moderating the 90-minute panel discussion is Eila Skinner, MD, chair of Stanford's Department of Urology. She is joined by other Stanford prostate cancer experts who will cover the following topics: Prostate Cancer Screening and Watchful Waiting - Benjamin Chung, MD, director of minimally invasive urologic surgery Update on Surgical Prostate Cancer Treatments - Mark Gonzalgo, MD, PhD, director of robotic-assisted urologic cancer surgery and physician leader of the Urologic Cancer Care Program New Treatments for Metastatic Prostate Cancer - Sandhya Srinivas, MD, a medical oncologist and member of the National Comprehensive Cancer Network's Prostate Panel For more information: stanfordhospital.org/prostatehealth
Просмотров: 7842 Stanford Health Care
Prostate Cancer - Treatment: Your Options
Prostate Cancer - Treatment: Your Options Visit http://www.troygianduzzo.com.au for more information
Просмотров: 82421 TroyGianduzzo
Advanced Prostate Cancer
(Visit: http://www.uctv.tv) Prostate cancer kills approximately 30,000 men in the US every year. For many, the disease is highly treatable and can be controlled with medical therapy for many years. An understanding of the factors that drive prostate cancer to become potentially lethal has led to a variety of new treatments that go far beyond standard chemotherapy approaches to cancer. Patients with advanced prostate cancer are currently treated with combinations and sequences of immunotherapies, hormonal approaches and chemotherapy. UCSF oncologist Dr. Charles J. Ryan covers the clinical and biological factors that drive treatment choice and sequence by physicians, and highlights how prostate cancer therapies are emblematic of the progress that is being made against cancer in general. Further, he addresses the challenges faced by patients and doctors and the research being done to address them. Recorded on 06/17/2014. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2014] [Health and Medicine] [Show ID: 28498]
Просмотров: 58658 University of California Television (UCTV)
Metastatic Prostate Cancer Treatment Options
Mayo Clinic Dr. Igor Frank discusses treatment options for patients with metastatic prostate cancer, and recommendations for follow up doctor visits and on-going PSA monitoring.
Просмотров: 6649 Mayo Clinic
Video of HIFU Prostate Cancer Treatment Procedure
Important Facts from the HIFU Video: The Sonablate 500 system is a computer controlled device designed for delivery of high intensity focused ultrasound (HIFU) to the prostate for treatment of prostate disease. Urologists have been using the Sonablate 500 system to treat localized prostate cancer, benign prostetic hyperplasia (BPH) and recurrent prostate cancer. The Sonablate 500 makes use of ultrasound imaging for real-time treatment monitoring, treatment planning and pre and post-treatment imaging of the prostate. Precise focusing of ultrasound energy during HIFU treatment elevates the temperature of the tissue in the focal zone very rapidly, while intervening tissue between the transducer and the focal zone is kept at a safe temperature. The result of HIFU therapy is an accurate and repeatable lesion at the target sites that are monitored in real time by the treating physician. All the treatment zones are pre-planned and checked by the physician prior to HIFU treatment. Please, watch the video to learn more and contact me to arrange a personal consultation regarding HIFU therapy using the Sonablate 500 system.
Просмотров: 15771 California HIFU
A note on prostate cancer by Dr. Saurabh Bhargava, Urology Consultant - NH Health City, Bangalore
Dr. Saurabh Bhargava, Urology Consultant at Narayana Health City, Bangalore, talks about how prostate cancer is one of the most commonly occurring cancers in men. He says that not all prostate cancer patients die of the disease, and not all prostate cancers need aggressive treatment. It is important for people to be aware of the disease and get appropriate treatment. Earlier diagnosis reduces the cost of treatment and the subsequent problems that arise from prostate cancer.
Просмотров: 1635 Narayana Health
William Aronson, MD - Prostate Cancer Research Symposium 2015
William Aronson, MD University of California, Los Angeles, CA
Просмотров: 121 David Geffen School of Medicine UCLA
Robotic Surgery for Kidney Cancer | UCLA Urology
Просмотров: 34463 UCLA Health
Targeted Focal Therapy for Localized Prostate Cancer
Dr. Ardeshir R. Rastinehad presented "Targeted Focal Therapy for Localized Prostate Cancer" at the 22nd Annual Scottsdale Prostate Cancer Symposium on Saturday, March 18, 2017.
Просмотров: 1328 Grand Rounds in Urology
USC Institute of Urology - Prostate Cancer Overview
Overview of USC Institute of Urology's program to treat prostate cancer. urology.keckmedicine.org keckmedicine.org
Просмотров: 454 Keck Medicine of USC
Prostate Cancer Treatment Options
Urologist Charles Modlin, MD, lays out a range of different treatment options if a biopsy shows that you have prostate cancer. Stay connected to Cleveland Clinic: ➨ Visit Cleveland Clinic: http://bit.ly/XlxDfr ➨ Visit Health Hub from Cleveland Clinic: http://bit.ly/VBQ3nW ➨ Subscribe to our YouTube Channel: http://bit.ly/W0bJ0y ➨ Like Cleveland Clinic on Facebook: http://on.fb.me/WMFkul ➨ Follow Cleveland Clinic on Twitter: http://bit.ly/Uua1Gs ➨ Follow Cleveland Clinic on Google+: http://bit.ly/136vcTe ➨ Follow Cleveland Clinic on Instagram: http://bit.ly/12gMABx ➨ Connect with Cleveland Clinic on LinkedIn: http://linkd.in/120XfNs ➨ Follow Cleveland Clinic on Pinterest: http://bit.ly/11QqS3A
Просмотров: 3447 Cleveland Clinic
Steam Treatment for Benign Prostatic Hyperplasia: Mayo Clinic Radio
Dr. Tobias Kohler, a urologist at Mayo Clinic, explains a promising new treatment for benign prostatic hyperplasia, or BPH. This interview originally aired on Feb. 24, 2018.
Просмотров: 43523 Mayo Clinic
Targeted Prostate Biopsy using MR-Ultrasound Fusion
Full details of fusion biopsy technique: http://casit.ucla.edu/body.cfm?id=222 A new research study at UCLA aims to re-define prostate cancer significance through clinical validation of a tool which allows 3D visualization and tracking of the prostate. By fusing multi-parametric MRI (T2-weighted, diffusion-weighted imaging, dynamic contrast enhancement) with real-time ultrasound, suspicious areas seen on the MRI can be tracked and targeted during prostate biopsy. This research aims to improve currently available methods of cancer diagnosis. Investigators: Leonard Marks, M.D. (Urology, http://usrf.org/about_usrf/founder.html) Daniel Margolis, M.D. (Radiology, http://www.radnet.ucla.edu/radweb/sections/abdominal/news/prostateMRI.jsp) Jiaoti Huang, M.D., Ph.D. (Pathology, http://faculty.pathology.ucla.edu/institution/personnel?personnel_id=622586).
Просмотров: 31157 UCLA Health